Michael B. Kastan

Executive Director, Duke Cancer Institute at Duke University Health System, Inc.

Michael B. Kastan

Michael B. Kastan

Executive Director, Duke Cancer Institute at Duke University Health System, Inc.

Overview
Career Highlights

Duke Cancer Institute
Duke University Health System, Inc.

RelSci Relationships

3748

Number of Boards

7

Number of Awards

1

Relationships
RelSci Relationships are individuals Michael B. Kastan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Friends of Cancer Research

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Professor Emeritus, Biochemistry & Biophysics at UCSF School of Medicine

Relationship likelihood: Strong

Co-Founder at PMV Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Gamida Cell Ltd.

Relationship likelihood: Strong

Founder at Cedilla Therapeutics, Inc.

Relationship likelihood: Strong

Director, Cancer Center at Cold Spring Harbor Laboratory

Relationship likelihood: Strong

Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center

Relationship likelihood: Strong

Professor & Chair, Department of Genetics, Division of Basic Science Research at University of Texas - MD Anderson Cancer Center

Relationship likelihood: Strong

Paths to Michael B. Kastan
Potential Connections via
Relationship Science
You
Michael B. Kastan
Executive Director, Duke Cancer Institute at Duke University Health System, Inc.
Education
PhD

A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School's 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children's hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.

Memberships
Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Career History
Director, Comprehensive Cancer Center
Prior

St. Jude is unlike any other pediatric treatment and research facility. Discoveries made here have completely changed how the world treats children with cancer and other catastrophic diseases. With research and patient care under one roof, St. Jude is where some of today's most gifted researchers are able to do science more quickly. The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family's ability to pay. Our vision is to be the world leader in advancing the treatment and prevention of catastrophic diseases in children. This vision will be pursued by providing outstanding patient care; by conducting basic, translational and clinical research designed to elucidate biological mechanisms, understand disease pathogenesis, improve diagnosis, enhance treatment outcome, prevent diseases and minimize adverse consequences of treatment; and by educating health care and scientific research professionals. Through these efforts we seek to cure and enhance the quality of life for an increasing proportion of children who come to us for treatment, and by expanding and sharing knowledge, to advance treatment of children with catastrophic diseases worldwide, while developing strategies to prevent catastrophic diseases in children.

Executive Director
Current

Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC.

Professor of Oncology & Pediatrics
Prior

The Johns Hopkins University School of Medicine (JHUSOM), located in Baltimore, Maryland, U.S., is the academic medical teaching and research arm of Johns Hopkins University. Johns Hopkins has consistently been among the nation's top medical schools in the number of research grants awarded by the National Institutes of Health.

Boards & Committees
Member, Advisory Board
Current

Aileron Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The firm engages in the development and commercialization of novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead products candidate, ALRN-6924 which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III and Loren David Walensky on August 6, 2001 and is headquartered in Watertown, MA.

Member, Board of Directors
Current

TO PUT AN END TO CANCER.

Member, Scientific Advisory Committee
Current

Stand Up To Cancer (SU2C) is a charitable program of the Entertainment Industry Foundation under the leadership of the Council of Founders and Advisors (CFA). SU2C is founded on the belief that there is a strong understanding of the basic science of cancer, and with the technologies available, now is the time to take that understanding to the next level by translating this knowledge to the clinic, to real advances in patient care and cancer prevention. It was founded in May 2008.

Member Emeritus, Scientific Advisory Board
Current

The William Guy Forbeck Research Foundation was launched with the help of dedicated people who cared for the Forbeck family and shared George and Jennifer’s vision. WGFRF has been blessed to have some of the original founding Directors and their children still active as well as new volunteers. Many individuals have volunteered their expertise and efforts to significantly benefit the foundation.

Chairman, Board of Scientific Counselors
Tenure Unconfirmed

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $999
2018

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

$500 - $2,499
2017

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

$1 - $999
2017

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Political Donations
$300
2005

Vice Chairman, Corporate & Institutional Banking at The PNC Financial Services Group, Inc.

Awards & Honors
American Association for Cancer Research - Clowes Memorial Award
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael B. Kastan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael B. Kastan's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael B. Kastan.